1. Acknowledgement to Referees

   ACKNOWLEDGEMENT TO REFEREES 09 November 2018 Pages: 615 - 617

2. Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood–Cerebrospinal Fluid Barrier and Blood–Brain Barrier

   • Lilian W. Kibathi
   • SoHyun Bae
   • Parag Kumar

   Review Article 01 June 2018 Pages: 619 - 635

   

3. Clinical Pharmacokinetics and Drug Interactions of Doravirine

   • Kyle John Wilby
   • Nesma Ahmed Eissa

   Review Article 25 July 2018 Pages: 637 - 644

4. Pharmacokinetic Profiling of Butylidenephthalide and Alisol B in Danggui-Shaoyao-San in Rats

   • Hui-fei Wu
   • Xiang-yu Wang
   • Wei-rong Li

   Original Research Article 27 April 2018 Pages: 645 - 653

   

5. Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats

   • Jing Sun
   • Xiaozhu Tang
   • Weidong Chen

   Original Research Article 02 May 2018 Pages: 655 - 664

   

6. Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients

   • Takaya Uno
   • Kyoichi Wada
   • Mitsutaka Takada

   Original Research Article 24 April 2018 Pages: 665 - 673

   

7. In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics

   • Renata Murgasova
   • Ester Tor Carreras
   • Julien Bourgailh

   Original Research Article 03 May 2018 Pages: 675 - 684

   

8. Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects

   • Dorien Groenendaal-van de Meent
   • Martin den Adel
   • Marloes Schaddelee

   Original Research Article Open access 11 May 2018 Pages: 685 - 692

   

9. Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents

   • Yoshiaki Ohtsu
   • Yoko Susaki
   • Kiyoshi Noguchi

   Original Research Article Open access 10 May 2018 Pages: 693 - 706

   

10. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes

    • Haitham AlRabiah
    • Abdul Ahad
    • Fahad I. Al-Jenoobi

    Original Research Article 09 May 2018 Pages: 707 - 713

    

11. Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo

    • Roland Heinig
    • Michael Gerisch
    • Stephanie Loewen

    Original Research Article 19 May 2018 Pages: 715 - 727

    

12. Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM^® Across Rich, Medium, and Sparse Sampling Data

    • Waroonrat Sukarnjanaset
    • Thitima Wattanavijitkul
    • Sutep Jarurattanasirikul

    Original Research Article 21 May 2018 Pages: 729 - 736

    

13. Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes

    • Jelle Reinen
    • Martijn Smit
    • Mira Wenker

    Original Research Article 21 May 2018 Pages: 737 - 750

    

14. Nutritional Status Differentially Alters Cytochrome P450 3A4 (CYP3A4) and Uridine 5′-Diphospho-Glucuronosyltransferase (UGT) Mediated Drug Metabolism: Effect of Short-Term Fasting and High Fat Diet on Midazolam Metabolism

    • Laureen A. Lammers
    • Roos Achterbergh
    • Ron A. A. Mathôt

    Original Research Article Open access 06 June 2018 Pages: 751 - 767

    

15. Retraction Note to: Changes of Absorptive and Secretory Transporting System of (1 → 3) β-D-glucan Based on Efflux Transporter in Indomethacin-induced Rat

    • Aiko Iida
    • Shohei Ouchi
    • Masahiro Hayashi

    Retraction Note 14 November 2018 Pages: 769 - 769